Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2011

Nov 15, 2011

30071_dirs_2011-11-15_467a6480-f285-4ea9-9a0c-19d38dd7f046.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2011-11-11

Reporting Person: Darkin Donald (President, SDB SBU)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-11-11 ResMed Common Stock F 4523 $28.04 Disposed 68334 Direct
2011-11-11 ResMed Common Stock F 4846 $28.04 Disposed 63488 Direct
2011-11-14 ResMed Common Stock S 11345 $27.612 Disposed 52143 Direct

Footnotes

F1: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 12/17/2009 and vesting on 11/11/2011.

F2: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 11/11/2010 and vesting on 11/11/2011.

F3: This transaction was executed in multiple trades at prices ranging from $27.612 to $27.64. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon requet to the SEC staff, the issuer or the security holder of the issuer.